At the Boğaziçi University Center for Targeted Therapy Technologies (CT³), we welcomed Prof. Dr. Šekib Umihanić, Director of the University Clinical Center Tuzla (UKC Tuzla), and shared information on our ongoing R&D activities and infrastructure capabilities.